SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Immunoglobulin-like beta-sandwich (7299)
(-)
Superfamily: Immunoglobulin (5995)
(-)
Family: V set domains (antibody variable domain-like) (1919)
(-)
Protein domain: automated matches (311)
(-)
Human (Homo sapiens) [TaxId: 9606] (85)
1T2JA:CRYSTAL STRUCTURE OF A HUMAN VH DOMAIN
1WT5C:; D:THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528
2A9MH:; I:STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM
2AGJL:1-107CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
2BX5A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O:IS FR1 THE ANTIBODY'S ACHILLIES HEEL
2D7TL:CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
2EIZA:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX
2EKSA:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX
2HP4A:; B:COMPUTATIONAL DESIGN AND CRYSTAL STRUCTURE OF AN ENHANCED AFFINITY MUTANT HUMAN CD8-ALPHA-ALPHA CO-RECEPTOR
2J12B:AD37 FIBRE HEAD IN COMPLEX WITH CAR D1
2J1KA:; B:; G:; J:; K:; O:; P:; T:; V:; X:; Y:; Z:CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
2KQMA:; B:SOLUTION STRUCTURE OF THE KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
2KQNA:; B:SOLUTION STRUCTURE OF THE AL-09 H87Y IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
2PYFB:1-113CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
2Q1EA:; B:; C:; D:ALTERED DIMER INTERFACE DECREASES STABILITY IN AN AMYLOIDOGENIC KAPPA1 BENCE JONES PROTEIN.
2Q20A:; B:STRUCTURE OF THE GERMLINE VK1 O18/O8 LIGHT CHAIN VARIABLE DOMAIN HOMODIMER
2UZIH:; L:CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV COMPLEX
2VH5H:; L:CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX
2VYRE:; F:; G:; H:; I:; J:; K:; L:STRUCTURE OF HUMAN MDM4 N-TERMINAL DOMAIN BOUND TO A SINGLE DOMAIN ANTIBODY
2W0KA:; B:CRYSTAL STRUCTURE OF THE RECOMBINANT VARIABLE DOMAIN 6JAL2
2W0LA:; B:; C:; D:CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2
2WBWB:AD37 FIBRE HEAD IN COMPLEX WITH CAR D1 AND SIALIC ACID
2X44D:STRUCTURE OF A STRAND-SWAPPED DIMERIC FORM OF CTLA-4
2XTJB:THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB
2YBRA:; D:; G:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YC1A:; D:CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN
2YSSA:CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HQ39KW47Y)-HEN LYSOZYME COMPLEX
3B5GA:; B:CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3B9VA:; B:; C:; D:CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN
3BDXA:; B:; C:CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3BQUA:1-107CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX
3BX7C:ENGINEERED HUMAN LIPOCALIN 2 (LCN2) IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HUMAN CTLA-4
3CDCA:; B:KI O18/O8 N34I/Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
3CDFA:; D:; E:; F:; B:; C:KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
3CDYA:; B:AL-09 H87Y, IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN
3DVFA:STRUCTURE OF AMYLOIDOGENIC KAPPA 1 BENCE JONES PROTEIN
3DVIA:CRYSTAL STRUCTURE OF KAPPA 1 AMYLOIDOGENIC LIGHT CHAIN VARIABLE DOMAIN
3DX9A:2-125; C:2-125CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3EYQC:1-108CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3F12A:1-108; C:1-108GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
3GSNB:2-116CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3H42L:1-112CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
3LRGA:; B:STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN
3LRHO:STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN IN COMPLEX WITH HUNTINGTIN PEPTIDE
3MLWL:1-107; M:1-107CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3OSKA:; B:CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER
3P9WB:; D:; F:; H:CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
3Q6FA:2-107; C:2-107; E:2-107; G:2-107; I:2-107; K:2-107CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
3QCTL:1-107CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
3QCUL:1-107; M:1-107CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
3QCVL:1-107; M:1-107CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
3QDGD:1-110THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJD:1-110THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QEGL:1-107CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEUA:1-110; D:0-110THE CRYSTAL STRUCTURE OF TCR DMF5
3QH3A:1-111; C:1-111THE CRYSTAL STRUCTURE OF TCR A6
3REVB:3-115CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3RRQA:CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN PD-1
3SDYL:1-107CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ
3SO3B:1-106ASTRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION.
3U79A:; B:; C:; D:; E:; F:; G:; H:AL-103 Y32F Y96F
3U7AA:AL-09 Y32F Y96F
3UPAA:; B:A GENERAL STRATEGY FOR THE GENERATION OF HUMAN ANTIBODY VARIABLE DOMAINS WITH INCREASED AGGREGATION RESISTANCE
3UPCA:; B:; C:; D:; E:; F:; G:; H:; I:; J:A GENERAL STRATEGY FOR THE GENERATION OF HUMAN ANTIBODY VARIABLE DOMAINS WITH INCREASED AGGREGATION RESISTANCE
3ZHDA:; B:THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-4 SCAFFOLD.
3ZHKA:THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD
3ZHLA:THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-14 SCAFFOLD
4AIXA:; B:; C:; D:CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT, 3RC34Y, OF THE GERMINAL LINE LAMBDA 3
4AJ0A:; B:; C:; D:CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT, 3RCW, OF THE GERMINAL LINE LAMBDA 3
4AM0B:1-107; D:1-107; F:1-107; L:1-107STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4DN3L:1-108CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
4FQLL:1-107INFLUENZA B HA ANTIBODY (FAB) CR8033
4FQQA:3-108; C:3-108; E:3-108; L:3-108CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
4GKZA:0-115; B:2-114HA1.7, A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4GRMA:2-117; C:1-117THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4HWEL:1-104CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4JDVB:2-103; L:1-103CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
4JFHD:1-110HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
4JM2C:1-109CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4K07A:; B:; C:; D:; E:; F:; G:; H:; I:; J:CRYSTAL STRUCTURE OF THE AMYLOID-FORMING IMMUNOGLOBULIN AL-103 CIS-PROLINE 95 MUTANT
4K3GA:; B:IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATING PROTEIN
4K3HA:; B:; C:; D:; E:; F:; G:; H:IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN
4KFZC:; D:CRYSTAL STRUCTURE OF LMO2 AND ANTI-LMO2 VH COMPLEX
4MWFB:3-107; L:2-107STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C